202 related articles for article (PubMed ID: 38650937)
1. Phenotypic comparison and the potential antitumor function of immortalized bone marrow-derived macrophages (iBMDMs).
Xie DK; Yao J; Li PH; Zhu YW; Chen JN; Cao XL; Cheng SL; Chen YM; Huang YF; Wang L; Wang ZH; Qiao R; Ge JM; Yue H; Wei L; Liu ZY; Han H; Qin HY; Zhao JL
Front Immunol; 2024; 15():1379853. PubMed ID: 38650937
[TBL] [Abstract][Full Text] [Related]
2. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778
[TBL] [Abstract][Full Text] [Related]
3. F1 fraction isolated from Mesobuthus eupeus scorpion venom induces macrophage polarization toward M1 phenotype and exerts anti-tumoral effects on the CT26 tumor cell line.
Sadeghi M; Amari A; Asadirad A; Nemati M; Khodadadi A
Int Immunopharmacol; 2024 May; 132():111960. PubMed ID: 38554440
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
5. Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages.
Ou DL; Chen CW; Hsu CL; Chung CH; Feng ZR; Lee BS; Cheng AL; Yang MH; Hsu C
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753566
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
8. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
[TBL] [Abstract][Full Text] [Related]
9. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
10. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
[TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
[TBL] [Abstract][Full Text] [Related]
12. VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization.
Jin S; Liu W; He X; Zhang Y; Chen W; Wu Y; Liu J
Int Immunopharmacol; 2024 Jul; 136():112365. PubMed ID: 38820964
[TBL] [Abstract][Full Text] [Related]
13. Tumor cells-derived conditioned medium induced pro-tumoral phenotypes in macrophages through calcium-nuclear factor κB interaction.
Zhang Y; Zhang Z; Chen L; Zhang X
BMC Cancer; 2022 Dec; 22(1):1327. PubMed ID: 36536301
[TBL] [Abstract][Full Text] [Related]
14. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
[TBL] [Abstract][Full Text] [Related]
15. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G
J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636
[TBL] [Abstract][Full Text] [Related]
16. Immortalization of Murine Bone Marrow-Derived Macrophages.
De Nardo D; Kalvakolanu DV; Latz E
Methods Mol Biol; 2018; 1784():35-49. PubMed ID: 29761386
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression.
Wang L; Hu YY; Zhao JL; Huang F; Liang SQ; Dong L; Chen Y; Yu HC; Bai J; Yang JM; Fan JY; Feng L; Li SZ; Han H; Qin HY
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948650
[TBL] [Abstract][Full Text] [Related]
18. Restoration of miR-340 controls pancreatic cancer cell
Xi Q; Zhang J; Yang G; Zhang L; Chen Y; Wang C; Zhang Z; Guo X; Zhao J; Xue Z; Li Y; Zhang Q; Da Y; Liu L; Yao Z; Zhang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503944
[TBL] [Abstract][Full Text] [Related]
19. Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages.
Arndt L; Dokas J; Gericke M; Kutzner CE; Müller S; Jeromin F; Thiery J; Burkhardt R
J Biol Chem; 2018 Jul; 293(29):11527-11536. PubMed ID: 29899113
[TBL] [Abstract][Full Text] [Related]
20.
Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
Front Immunol; 2021; 12():658681. PubMed ID: 34093546
[No Abstract] [Full Text] [Related]
[Next] [New Search]